Evidence map›Paper›PMID 26554720›Full record

ReviewPediatric cardiology2016

Circulating Progenitor Cells and Childhood Cardiovascular Disease.

Eric J Kort, Lacey Croskey, Taryn Scibienski, Surender Rajasekaran, Stefan Jovinge

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pediatric cardiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Eric J KortDeVos Cardiovascular Research Program of Spectrum Health and Van Andel Research Institute, 100 Michigan Street NE, Grand Rapids, MI, 49503, USA. eric.kort@vai.org.ORCID http://orcid.org/0000-0002-9966-7483
Lacey CroskeyMichigan State University, College of Human Medicine, 15 Michigan Street NE, Grand Rapids, MI, USA.
Taryn ScibienskiMichigan State University, College of Human Medicine, 15 Michigan Street NE, Grand Rapids, MI, USA.
Surender RajasekaranMichigan State University, College of Human Medicine, 15 Michigan Street NE, Grand Rapids, MI, USA.
Stefan JovingeDeVos Cardiovascular Research Program of Spectrum Health and Van Andel Research Institute, 100 Michigan Street NE, Grand Rapids, MI, 49503, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circulating progenitor cells have been extensively studied in the context of heart disease in adults. In these patients, they have been demonstrated to be markers of myocardial injury and recovery as well as potential therapeutic agents. However, studies in children are much more limited. Here we review current knowledge pertaining to circulating progenitor cells in the context of childhood cardiovascular disease. Priorities for further research are also highlighted.

Indexed as

Cardiopulmonary BypassCardiovascular DiseasesChildHeart Defects, CongenitalHumansMembrane ProteinsStem CellsMembrane ProteinsCardiopulmonary bypassCongenital heart diseaseProgenitor cellsStem cells

Identifiers

PMID26554720

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.